Investigating the role of a specific protein in lung fibrosis related to scleroderma
The role of BHLHB2 in Scleroderma-Associated Lung Fibrosis
This study is looking at how a protein called BHLHB2 affects lung scarring in people with scleroderma, hoping to find new ways to help treat lung problems caused by this condition.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-10899503 on NIH RePORTER |
What this research studies
This research focuses on understanding how the protein BHLHB2 contributes to lung fibrosis in patients with scleroderma, a serious autoimmune disease. The study examines the relationship between inflammatory signals and the production of fibrotic factors in lung cells. By analyzing how these factors interact, researchers aim to identify potential new targets for treatment. Patients may benefit from insights that could lead to more effective therapies for pulmonary fibrosis associated with scleroderma.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with scleroderma who are experiencing lung fibrosis.
Not a fit: Patients with lung fibrosis not related to scleroderma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients suffering from lung fibrosis due to scleroderma.
How similar studies have performed: Previous research has shown promising results in targeting similar pathways in fibrotic diseases, suggesting potential for success in this approach.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Adewale, Adegboyega Timothy — Medical University of South Carolina
- Study coordinator: Adewale, Adegboyega Timothy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.